Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Nexstim Plc

Market Cap 80.26M 92.06M 74.34M 69.59M 131M 8.69B 131M 882M 342M 4.28B 346M 338M 14.85B P/E 2026 *
82.8x
P/E 2027 * 36.8x
Enterprise Value 78.16M 89.65M 72.39M 67.77M 127M 8.46B 128M 859M 333M 4.16B 337M 329M 14.46B EV / Sales 2026 *
6.15x
EV / Sales 2027 * 4.76x
Free-Float
58.2%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 11/02/2020
Director of Finance/CFO 40 11/02/2020
Chief Tech/Sci/R&D Officer 65 01/01/2008
Director TitleAgeSince
Director/Board Member 64 11/11/2019
Chairman 63 11/11/2019
Director/Board Member 55 01/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 92.06M
+0.63%-1.01%+18.35%-13.53% 173B
+1.14%-1.04%-20.16%+23.51% 144B
-0.33%-1.63%-8.88%-26.73% 125B
+0.76%-3.45%-55.32%-16.62% 67.32B
+0.78%+2.64%+18.09%-4.98% 50.3B
-0.58%-1.16%-25.42%-34.65% 43.8B
+2.20%-2.14%+9.99%+4.90% 35.89B
-0.44%-0.03%+4.74%+32.04% 34.9B
+0.72%-5.51%-14.33%-21.69% 28.02B
Average +0.49%-1.86%-8.11%-6.42% 78.04B
Weighted average by Cap. +0.54%-1.89%-6.63%-6.41%

Financials

2026 *2027 *
Net sales 12.7M 14.57M 11.76M 11.01M 20.65M 1.37B 20.78M 140M 54.08M 677M 54.68M 53.5M 2.35B 16.1M 18.47M 14.91M 13.96M 26.18M 1.74B 26.34M 177M 68.56M 858M 69.31M 67.83M 2.98B
Net income 1M 1.15M 926K 867K 1.63M 108M 1.64M 10.99M 4.26M 53.27M 4.31M 4.21M 185M 2.2M 2.52M 2.04M 1.91M 3.58M 238M 3.6M 24.17M 9.37M 117M 9.47M 9.27M 407M
Net Debt -2.1M -2.41M -1.94M -1.82M -3.41M -227M -3.44M -23.07M -8.94M -112M -9.04M -8.85M -388M -3.7M -4.24M -3.43M -3.21M -6.02M -400M -6.05M -40.65M -15.76M -197M -15.93M -15.59M -684M
Logo Nexstim Plc
Nexstim Oyj is a Finland-based medical technology company. It is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.
Employees
40
Trader
Investor
Global
Quality
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!